Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017, Article ID 2190812, 9 pages
https://doi.org/10.1155/2017/2190812
Research Article

Views and Experiences of New Zealand Women with Gestational Diabetes in Achieving Glycaemic Control Targets: The Views Study

Liggins Institute, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand

Correspondence should be addressed to Caroline A. Crowther; zn.ca.dnalkcua@rehtworc.c

Received 7 August 2017; Accepted 12 October 2017; Published 31 October 2017

Academic Editor: Bernard Portha

Copyright © 2017 Ruth Martis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King, “Global prevalence of diabetes: estimates for the year 2000 and projections for 2030,” Diabetes Care, vol. 27, pp. 1047–1053, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. Ministry of Health, Diabetes in Pregnancy: Quick Reference Guide for Health Professionals on the Screening, Diagnosis and Treatment of Gestational Diabetes in New Zealand, Ministry of Health, Wellington, New Zealand, 2014.
  3. L. Guariguata, U. Linnenkamp, J. Beagley, D. R. Whiting, and N. H. Cho, “Global estimates of the prevalence of hyperglycaemia in pregnancy,” Diabetes Research and Clinical Practice, vol. 103, no. 2, pp. 176–185, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. U. Kampmann, L. Ring Madsen, G. Oeskov Skajaa, D. Smed Iversen, N. Moeller, and P. Ovesen, “Gestational diabetes: a clinical update,” World Journal of Diabetes, vol. 6, no. 8, pp. 1065–1072, 2015. View at Publisher · View at Google Scholar
  5. World Health Organization (WHO), Global Report on Diabetes. WK 810, World Health Organization, Geneva, Switzerland, 2016.
  6. NICE, National Institute for Health and Clinical Excellence, Diabetes in Pregnancy: Management of Diabetes and its Complications from Preconception to the Postnatal Period. NICE Guideline NG3, National Institute for Health and Care Excellence, London, UK, 2015.
  7. HAPO Study Cooperative Research Group, B. E. Metzger, L. P. Lowe et al., “Hyperglycemia and adverse pregnancy outcomes,” New England Journal of Medicine, vol. 358, no. 19, pp. 1991–2002, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. J. M. Nicklas, L. J. Miller, C. A. Zera, R. B. Davis, S. E. Levkoff, and E. W. Seely, “Factors associated with depressive symptoms in the early postpartum period among women with recent gestational diabetes mellitus,” Maternal and Child Health Journal, vol. 17, no. 9, pp. 1665–1672, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Lucas, R. Morley, and T. Cole, “Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia,” BMJ, vol. 29, no. 6659, pp. 1304–1308, 1988. View at Publisher · View at Google Scholar
  10. A. Ornoy, E. A. Reece, G. Pavlinkova, C. Kappen, and R. K. Miller, “Effect of maternal diabetes on the embryo, fetus, and children: congenital anomalies, genetic and epigenetic changes and developmental outcomes,” Birth Defects Research Part C: Embryo Today: Reviews, vol. 105, no. 1, pp. 53–72, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Mitanchez, C. Yzydorczyk, and U. Simeoni, “What neonatal complications should the pediatrician be aware of in case of maternal gestational diabetes?” World Journal of Diabetes, vol. 6, no. 5, pp. 734–743, 2015. View at Publisher · View at Google Scholar
  12. N. Poolsup, N. Suksomboon, and M. Amin, “Effect of treatment of gestational diabetes mellitus: a systematic review and meta-analysis,” PLoS One, vol. 9, no. 3, article e92485, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. M. B. Landon, C. Y. Spong, E. Thom et al., “A multicenter, randomized trial of treatment for mild gestational diabetes,” New England Journal of Medicine, vol. 361, no. 14, pp. 1339–1348, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. C. A. Crowther, J. E. Hiller, J. R. Moss, A. J. McPhee, W. S. Jeffries, and J. S. Robinson, “Effect of treatment of gestational diabetes mellitus on pregnancy outcomes,” New England Journal of Medicine, vol. 352, no. 24, pp. 2477–2486, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Brown, N. A. Alwan, J. West et al., “Lifestyle interventions for the treatment of women with gestational diabetes,” Cochrane Database of Systematic Reviews, vol. 5, article CD011970, 2017. View at Publisher · View at Google Scholar
  16. Z. Nachum, N. Zafran, R. Salim et al., “Glyburide versus metformin and their combination for the treatment of gestational diabetes mellitus: a randomized controlled study,” Diabetes Care, vol. 40, no. 2, pp. 332–337, 2017. View at Publisher · View at Google Scholar
  17. B. Kalra, Y. Gupta, R. Singla, and S. Klara, “Use of oral anti-diabetic agents in pregnancy: a pragmatic approach,” North American Journal of Medical Sciences, vol. 7, no. 1, pp. 6–12, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. R. J. Ryu, K. E. Hays, and M. F. Hebert, “Gestational diabetes mellitus management with oral hypoglycemic agents,” Seminars in Perinatology, vol. 38, no. 8, pp. 508–515, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Kavitha, S. De, and S. Kanagasabai, “Oral hypoglycemic agents in pregnancy: an update,” The Journal of Obstetrics and Gynecology of India, vol. 63, no. 2, pp. 82–87, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Parsons, K. Ismail, S. Amiel, and A. Forbes, “Perceptions among women with gestational diabetes,” Qualitative Health Research, vol. 24, no. 4, pp. 575–585, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. M. K. Morrison, J. M. Lowe, and C. E. Collins, “Australian women’s experiences of living with gestational diabetes,” Women and Birth, vol. 27, no. 1, pp. 52–57, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Trutnovsky, T. Panzitt, E. Magnet, C. Stern, U. Lang, and M. Dorfer, “Gestational diabetes: women’s concerns, mood state, quality of life and treatment satisfaction,” The Journal of Maternal-Fetal & Neonatal Medicine, vol. 25, no. 11, pp. 2464–2466, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. J. E. Hirst, S. T. Thach, T. D. My An, R. Forsyth, J. M. Morris, and H. E. Jeffery, “Women with gestational diabetes in Vietnam: a qualitative study to determine attitudes and health behaviours,” BMC Pregnancy and Childbirth, vol. 12, no. 1, pp. 81–90, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Lapolla, G. Di Cianni, A. Di Benedetto et al., “Quality of life, wishes, and needs in women with gestational diabetes: Italian DAWN pregnancy study,” International Journal of Endocrinology, vol. 2012, Article ID 784726, 6 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Bandyopadhyay, R. Small, M. Davey, J. J. N. Oats, D. A. Forster, and A. Aylward, “Lived experience of gestational diabetes mellitus among immigrant South Asian women in Australia,” Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 51, pp. 360–364, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. http://www.health.govt.nz/new-zealand-health-system/my-dhb/counties-manukau-dhb/population-counties-manukau-dhb. July 2017.
  27. http://www.health.govt.nz/new-zealand-health-system/my-dhb/canterbury-dhb/population-canterbury-dhb. July 2017.
  28. http://www.stats.govt.nz/browse_for_stats/population/census_counts/2013CensusUsuallyResidentPopulationCounts_HOTP2013Census.aspx. July 2017.
  29. S. S. Russell, “An overview of adult-learning processes,” Urologic Nursing, vol. 26, no. 5, pp. 349–352, 370, 2006. View at Google Scholar
  30. D. H. Frøisland, E. Årsand, and F. Skårderud, “Improving diabetes care for young people with type 1 diabetes through visual learning on mobile phones: mixed-methods study,” Journal of Medical Internet Research, vol. 14, no. 4, pp. 113–125, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. B. U. Devsam, F. E. Bogossian, and A. S. Peacock, “An interpretive review of women’s experiences of gestational diabetes mellitus: proposing a framework to enhance midwifery assessment,” Women and Birth, vol. 26, no. 2, pp. e69–e76, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. Ministry of Health, A Framework for Health Literacy, Ministry of Health, Wellington, New Zealand, 2015.
  33. Work base Education Trust, Māori Health Literacy Research: Gestational Diabetes Mellitus, Ministry of Health, Wellington, New Zealand, 2014.
  34. B. Bhavadharini, M. Deepa, S. Nallaperumal, R. M. Anjana, and V. Mohan, “Knowledge about gestational diabetes mellitus amongst pregnant women in South Tamil Nadu,” Journal of Diabetology, vol. 8, pp. 22–26, 2017. View at Publisher · View at Google Scholar
  35. B. Gray, “The use of interpreters, chapter 8,” in Cole’s Medical Practice in New Zealand, I. M. St. George, Ed., Medical Council of New Zealand, Wellington, New Zealand, 12th edition, 2013. View at Google Scholar
  36. M. F. Carroll and D. S. Schade, “The dawn phenomenon revisited: implications for diabetes therapy,” Endocrine Practice, vol. 11, no. 1, pp. 55–64, 2005. View at Publisher · View at Google Scholar
  37. F. Porcellati, P. Lucidi, G. B. Bolli, and C. G. Fanelli, “Thirty years of research on the Dawn phenomenon: lessons to optimize blood glucose control in diabetes,” Diabetes Care, vol. 36, no. 12, pp. 3860–3862, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. http://www.gestationaldiabetes.co.uk/high-fasting-levels/.
  39. J. P. Sheehan, “Fasting hyperglycemia: etiology, diagnosis, and treatment,” Diabetes Technology & Therapeutics, vol. 6, no. 4, pp. 525–533, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Fahy, “What is woman-centred care and why does it matter?” Women and Birth, vol. 25, pp. 149–151, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Janes, J. Titchener, J. Pere, and R. Pere, “Understanding barriers to glycaemic control from the patient’s perspective,” Journal of Primary Health Care, vol. 5, no. 2, pp. 114–122, 2013. View at Google Scholar
  42. T. A. Miller and M. R. DiMatteo, “Importance of family/social support and impact on adherence to diabetic therapy,” Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, vol. 6, pp. 421–426, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. L. S. Mayberry and C. Y. Osborn, “Family support, medication adherence and glycemic control among adults with type 2 diabetes,” Diabetes Care, vol. 35, pp. 1239–1245, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. World Health Organization (WHO), Obesity: Preventing and Managing the Global Epidemic, Report of a WHO Consultation, WHO Technical Report Series 894, Geneva, Switzerland, 2000.
  45. Ministry of Health, Understanding Excess Body Weight: New Zealand Health Survey, Ministry of Health, Wellington, New Zealand, 2015.